Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Sinobioway to Invest $471 Million Build a CMO Site in Hefei

publication date: May 7, 2018

Shandong Sinobioway Biomedicine Co., Ltd. – a Sinobioway company, decided to build an antibody CMO site located in the Sinobioway biomedical industry park. The new CMO will offer complete manufacturing service, including research labs, 3×500L commercial production, 500L pivot scale, 200L pivot scale, formulation, storage and quality control. By 2023, it is expected to receive $471 million and have 500,000L capacity in the CMO. More details....

Stock Symbol: (SZEX: 002581)

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here